Stereotactic body radiation therapy for early-stage non-small-cell lung cancer.
Stereotactic body radiation therapy has emerged as a novel oncologic therapy and experience with the use of stereotactic body radiation therapy for the treatment of early-stage non-small-cell lung cancer has grown over the last 10 years. This article reviews the radiobiologic, physical/technical and clinical aspects of stereotactic body radiation therapy for early-stage non-small-cell lung cancer. The literature is also reviewed.
Lo
Simon S
SS
Ohio State University Medical Center, Department of Radiation Medicine, Arthur G James Cancer Hospital, 300 West 10th Avenue, Suite 088A, Columbus, OH 43210, USA. simon.lo@osumc.edu
Fakiris
Achilles J
AJ
Papiez
Lech
L
Abdulrahman
Ramzi
R
McGarry
Ronald C
RC
Henderson
Mark A
MA
Forquer
Jeffrey A
JA
Hoopes
David
D
Timmerman
Robert D
RD
D002289:Carcinoma, Non-Small-Cell Lung / Q000532:radiotherapy*; D006801:Humans; D008175:Lung Neoplasms / Q000532:radiotherapy*; D013238:Stereotaxic Techniques